Paid Clinical Trials in Chattanooga, TN
As of September 2026, 126 paid clinical trials are recruiting in Chattanooga, Tennessee. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Chattanooga offers studies at sites including T C Thompson Children's Hospital for conditions such as Carcinoma, Non-Small-Cell Lung, Generalized Myasthenia Gravis, AChR-Ab Seropositive Generalized Myasthenia Gravis, Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Chattanooga
Trials by drug in Chattanooga
Filter results
Newly added in Chattanooga
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Tablets.
118 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Top Research Study Locations in Chattanooga
Researchers run research studies in Chattanooga, TN at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| T C Thompson Children's Hospital | Acute Myeloid Leukemia, Adrenal Gland Pheochromocytoma, B Acute Lymphoblastic Leukemia | 6 |
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease, Irritable Bowel Syndrome, Multiple Myeloma | 5 |
| Erlanger Health System | AChR-Ab Seropositive Generalized Myasthenia Gravis, gMG, Generalized Myasthenia Gravis | 5 |
| Southeast Renal Research Institute | Diabetic Kidney Disease (DKD), End Stage Kidney Disease, Focal Segmental Glomerulosclerosis | 4 |
| Tennessee Oncology, PLLC - Chattanooga Downtown | Advanced Non-Small Cell Lung Cancer, Advanced/Metastatic Urothelial Cancer, Cancer of the Prostate | 4 |
| Tennessee Oncology, PLLC - Chattanooga Med Park II | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Advanced/Metastatic Urothelial Cancer | 4 |
| Tennessee Oncology, PLLC - Chattanooga Memorial | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Advanced/Metastatic Urothelial Cancer | 4 |
| Erlanger Health, Inc. | Cardiovascular Disease, Endometrioid Ovarian Cancer, Fallopian Tube Cancer | 3 |
| Tennessee Oncology | Advanced Solid Tumors, Colorectal Cancer (CRC), MF | 3 |
| Tennessee Oncology - Chattanooga | Carcinoma, Non-Small-Cell Lung, Melanoma, Metastatic Castration-resistant Prostatic Neoplasms | 3 |
| Tennessee Oncology Chattanooga | Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Neoplasm Metastasis | 3 |
| Tennessee Oncology, PLLC - Investigational Drug Services/Supply Storage | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Advanced/Metastatic Urothelial Cancer | 3 |
| University Diabetes & Endocrine Consultants | T1D, T1DM, T1DM - Type 1 Diabetes Mellitus | 3 |
| Vascular Institute of Chattanooga | Arteriovenous Fistula, Chronic Total Occlusion of Artery of the Extremities, End-stage Renal Disease | 3 |
| Clinical Trial Site | Generalized Myasthenia Gravis, High Cardiovascular Risk, High Risk Cardiovascular Disease | 2 |
| ClinSearch, LLC | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 2 |
| Erlanger Health | Epithelial Ovarian Cancer, Fallopian Tube Cancer, Heart Failure | 2 |
| Galen Medical Group - Galen Hepatology | Hepatitis, Metabolic Dysfunction-Associated Steatotic Liver Disease | 2 |
| Tennessee Oncology PLLC | Prostate Cancer, Cancer of the Prostate, Hormone Sensitive Prostate Cancer | 2 |
| Tennessee Oncology, PLLC | Acinar Cell Carcinoma, Advanced Cancer, Breast Cancer | 2 |
| Tennessee Oncology, PLLC - Chattanooga East | Advanced/Metastatic Urothelial Cancer, Cancer of the Prostate, Hormone Sensitive Prostate Cancer | 2 |
| WR-ClinSearch, LLC | Acute Migraine, Migraine | 2 |
| WR-Clinsearch, LLC | Atherosclerotic Cardiovascular Disease (ASCVD), COVID-19 SARS-CoV-2 Infection, Elevated Lp(a) | 2 |
| Woolfson Eye Institute | Forme Fruste Keratoconus (FFK), Keratoconus, Down Syndrome (DS) | 2 |
| Erlanger Medical Center | Atrial Fibrillation, Implant, Oral Anticoagulation | 2 |
Active & Upcoming Studies in Chattanooga (2026)
Recruiting trials in Chattanooga grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (42 active studies)
- Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer · Phase 1, Phase 2 · Pfizer
- Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer · Phase 1, Phase 2 · Pfizer
Diabetes & metabolic (11 active studies)
- A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar · Phase 3 · Boehringer Ingelheim
- Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes · Insulet Corporation
Cardiovascular (9 active studies)
Neurology & pain (8 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Vaccines (2 active studies)
Pediatric (1 active study)
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) · Phase 1, Phase 2 · COUR Pharmaceutical Development Company, Inc.
Common conditions studied in Chattanooga
- Carcinoma, Non-Small-Cell Lung (5 active studies)
- Generalized Myasthenia Gravis (4 active studies)
- AChR-Ab Seropositive Generalized Myasthenia Gravis (3 active studies)
- Breast Cancer (3 active studies)
- Chronic Lymphocytic Leukemia (3 active studies)
- Fallopian Tube Cancer (3 active studies)
Leading research sponsors in Chattanooga
- AstraZeneca
- Pfizer
- Boehringer Ingelheim
- Children's Oncology Group
- GlaxoSmithKline
Frequently asked questions
How many paid clinical trials are currently recruiting in Chattanooga?
There are approximately 126 recruiting clinical trials in Chattanooga, Tennessee listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Chattanooga pay participants?
Most recruiting trials in Chattanooga compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Chattanooga?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Chattanooga?
The most common conditions under active study in Chattanooga include Carcinoma, Non-Small-Cell Lung (5), Generalized Myasthenia Gravis (4), AChR-Ab Seropositive Generalized Myasthenia Gravis (3), Breast Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Chattanooga?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Chattanooga on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Chattanooga?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Chattanooga?
Recruiting research sites in Chattanooga include T C Thompson Children's Hospital, GSK Investigational Site, Erlanger Health System, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Chattanooga right now?
The largest active categories in Chattanooga are Cancer & tumors (42), Diabetes & metabolic (11), Cardiovascular (9). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.